Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the impact of atorvastatin 20mg qd and Vitamin E 300mg
qd therapy on liver fat content in patients with type 2 diabetes associated with high LDL-C
and non-alcoholic fatty liver disease.
Phase:
Phase 4
Details
Lead Sponsor:
Xin Gao
Collaborator:
Pfizer
Treatments:
alpha-Tocopherol Atorvastatin Atorvastatin Calcium Tocopherols Tocotrienols Vitamin E Vitamins